Cytek Biosciences (CTKB) Revenue Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 7.30% |
| 10 | Cytek Biosciences | 609.76 Mn | 535.91 Mn | 28.34 Mn | 5.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.57% |
| Mar 31, 2026 | 6.46% |
| Dec 31, 2025 | 8.12% |
| Sep 30, 2025 | 1.54% |
| Jun 30, 2025 | -2.18% |
| Mar 31, 2025 | -7.59% |
| Dec 31, 2024 | -1.30% |
| Sep 30, 2024 | 7.29% |
| Jun 30, 2024 | -6.19% |
| Mar 31, 2024 | 20.96% |
| Dec 31, 2023 | 20.48% |
| Sep 30, 2023 | 18.59% |
| Jun 30, 2023 | 23.74% |
| Mar 31, 2023 | 5.77% |
| Dec 31, 2022 | 24.28% |
| Sep 30, 2022 | 17.75% |
| Jun 30, 2022 | 32.07% |
| Mar 31, 2022 | 44.46% |
| Dec 31, 2021 | 27.03% |
| Sep 30, 2021 | 36.98% |